In males, AES often presents with symptoms such as gynecomastia (enlarged breast tissue), early onset of puberty, and reduced fertility. Females may experience symptoms like irregular menstrual cycles, early breast development, and increased risk of estrogen-related conditions. Both genders may exhibit short stature due to early closure of growth plates in bones.

Diagnosing AES involves a combination of clinical evaluation and laboratory tests. Blood tests are conducted to measure hormone levels, particularly estrogen and androgen levels. Genetic testing may be performed to identify mutations in the CYP19A1 gene, which is responsible for encoding the aromatase enzyme. Imaging studies, such as ultrasound or MRI, may be used to assess any physical abnormalities.

Treatment for AES focuses on managing symptoms and reducing estrogen levels. Medications such as aromatase inhibitors can be prescribed to block the production of estrogen. In some cases, surgical intervention may be necessary to address gynecomastia or other physical manifestations. Hormone therapy may also be considered to balance hormone levels.

The prognosis for individuals with AES varies depending on the severity of symptoms and the effectiveness of treatment. With appropriate management, many patients can lead normal lives. However, ongoing monitoring and treatment adjustments may be necessary to address hormonal imbalances and prevent complications.

AES is primarily caused by genetic mutations in the CYP19A1 gene, which leads to increased activity of the aromatase enzyme. These mutations can be inherited in an autosomal dominant pattern, meaning a single copy of the mutated gene from either parent can cause the condition.

Aromatase Excess Syndrome is extremely rare, with only a limited number of cases reported in the medical literature. Due to its rarity, the exact prevalence is unknown, and it may be underdiagnosed or misdiagnosed as other hormonal disorders.

The pathophysiology of AES involves the overproduction of the aromatase enzyme, which converts androgens into estrogens at an increased rate. This leads to elevated estrogen levels, disrupting the normal balance of sex hormones in the body. The excess estrogen can cause various physical and developmental changes, particularly during puberty.

Currently, there are no known methods to prevent AES, as it is a genetic condition. Genetic counseling may be beneficial for families with a history of the disorder to understand the risks and implications of passing the condition to offspring.

Aromatase Excess Syndrome is a rare genetic disorder characterized by excessive production of the aromatase enzyme, leading to elevated estrogen levels. It presents with various symptoms related to hormonal imbalance and requires a combination of clinical evaluation, laboratory tests, and genetic testing for diagnosis. Treatment focuses on managing symptoms and reducing estrogen levels, with a generally favorable prognosis when appropriately managed.

For patients and families affected by Aromatase Excess Syndrome, understanding the condition is crucial. It is a genetic disorder that causes an imbalance in hormone levels due to increased estrogen production. Symptoms can vary but often include changes in physical development and reproductive health. While the condition is rare, effective treatments are available to manage symptoms and improve quality of life. Regular follow-up with healthcare providers is important to monitor hormone levels and adjust treatment as needed.